Skip to content
Open access

Persistent lipotoxicity overwhelms adaptive capacity in human hepatic cell line.

Aug 2026 · Journal of NutriLife · Vol 156, pp. 101774 · 0 citations · 62 references
Medicine

TL;DR

Sustained PA/OA exposure induces a staged hepatocellular response, early lipid-buffering adaptation, intermediate metabolic compensation, and late decompensation, indicating that chronic lipotoxicity reflects progressive loss of regulatory coordination despite persistent metabolic adaptation.

Abstract

Background

Chronic fatty acid (FA) elevation drives metabolic dysfunction-associated liver disease (MASLD). Hepatocytes buffer transient lipid overload via coordinated adaptive mechanisms, but the temporal limits of this capacity remain undefined.

Objectives

We characterized early, intermediate, and prolonged hepatocellular responses to sustained lipid excess.

Methods

HuH7 hepatocytes were exposed to an equimolar palmitic/oleic acid (PA/OA) mixture for 1, 14, or 28 days. Viability, lipid accumulation, stress-response pathways, insulin signaling, metabolic regulators, mitochondrial markers, [14C]-PA uptake, and exo-metabolomic profiles were assessed (n≥3/group). Data (mean ± SEM) were analyzed by two-way ANOVA with Bonferroni post hoc testing; cumulative cell death by linear regression. P<0.05 was significant.

Results

FA treatment increased lipid droplet accumulation 1.4- to 1.7-fold vs. time-matched BSA controls at all time points (p<0.001) and increased the rate of cumulative cell death ∼4.3-fold (1.556±0.083 vs. 0.365±0.054%/day, p<0.001). Exo-metabolomic PCA explained 88.5% of variance (Q2=0.758), with peak lactate release at Day 14 and progressively rising acetate through Day 28. [14C]-PA accumulation at Day 28 was ∼30% lower than Day 1 (∼800 vs. ∼500 cpm/mg protein), with a declining rather than plateauing profile between 20-60 s. By Day 28, FA-treated cells showed lower FASN (p<0.001), CD36 (p<0.05), FABP1 (p<0.001), SIRT1 (p<0.005), and CLOCK (p<0.01) protein levels, and higher CPT1A (p<0.001), pAMPK/AMPK (p<0.01), p53 (p<0.001), Bax/Bcl2 (p<0.005), and respiratory complex I-V abundance (p<0.05-p<0.001) vs. controls.

Conclusions

Sustained PA/OA exposure induces a staged hepatocellular response, early lipid-buffering adaptation, intermediate metabolic compensation, and late decompensation, indicating that chronic lipotoxicity reflects progressive loss of regulatory coordination despite persistent metabolic adaptation.

Read PDF

Similar papers

Open access Sep 2026

Lipotoxicity Amplifies IL-6 Trans-Signaling in Sinusoidal Endothelial Cells to Promote Endotheliopathy and Liver Injury.

BACKGROUND AND AIMS Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 25% of the global population and is a major health concern. Liver sinusoidal endothelial cells (LSECs) undergo morphological and functional alterations during MASLD progression, resulting in endotheliopathy charac...

Yasuhiko Ueda, Nao Kawaguchi, Yosuke Inomata et al. · 0 citations
Sep 2026

MRP4 deficiency exacerbates diet-induced MASLD through dysregulation of hepatic lipid handling.

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is characterized by impaired hepatic lipid homeostasis. Multidrug resistance-associated protein 4 (MRP4/ABCC4) is a sinusoidal efflux transporter of endogenous signaling metabolites. We previously showed that Mrp4 knockout (Mrp4-/-) mice develop prolonged...

Hang-Yu Wu, Ankit P. Laddha, Neha Mishra et al. · 0 citations
Open access Sep 2026

Transcriptomic Architecture of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Risk in Mexican Americans

Highlights What are the main findings? Hepatic steatosis (neutral lipid) measures in iPSC-derived hepatocyte cultures showed statistically significant additive genetic heritability at baseline (h2 = 0.44, p ≤ 0.05) and post-lipid challenge (h2 = 0.42, p ≤ 0.05). Transcriptome-wide association analysis identified 1070 g...

Satish Kumar, Miriam Aceves, Lorena Guerra et al. · 0 citations
Open access Aug 2026

Integrated Hepatic Lipidome Analysis in Aging Mice.

Age-associated changes in lipid profiles in the liver of adult mice were consistently observed across multiple mass spectrometry platforms, and are linked to membrane structure, signaling, and metabolism, providing new insights into age-related liver dysfunction.

Punyatoya Panda, C. Ferreira, Allison J. Schaser et al. · 0 citations
Sep 2026

Liraglutide Attenuates Hepatocyte Ferroptosis in an In Vitro Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Liraglutide demonstrated the ability to mitigate lipid accumulation, oxidative stress, and iron overload in HepG2 cells subjected to FFA-induced injury, suggesting a mechanistic basis for the potential protective role of liraglutide in MASLD.

J. Bai, Y. Xiao, P. Lou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.